assessment for [90:3+ or 4+ 1 Negative stool guaiac test results 1 Hepatic Signs of hepatic failure, including encephalopathy, increasing ascites, liver pain, or hypoglycemia 1 When all signs of hepatic failure have resolved; initiate a new course of treatment (if warranted) 7 weeks after cessation of adverse events and hospital discharge 1 Infectious complications Sepsis syndrome occurs and patient is clinically unstable 1 Sepsis syndrome resolved, patient is clinically stable and infection is being treated 1 Neurologic Changes in mental status (e.g., moderate confusion, agitation) 1 Mental status changes completely resolved 1 Renal S cr 4.5 mg/dL or 4 mg/dL in presence of severe volume overload, acidosis, or hyperkalemia 1 S cr] FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx Availability Prescription only C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Drug Class Interleukins Miscellaneous antineoplastics Related Drugs Renal Cell Carcinoma Avastin , Opdivo , nivolumab , Nexavar , Afinitor , Sutent , bevacizumab , Votrient , More... Melanoma Opdivo , Keytruda , nivolumab , pembrolizumab , Yervoy , ipilimumab , Proleukin , dacarbazine , More... Melanoma, Metastatic Opdivo , Keytruda , nivolumab , pembrolizumab , Yervoy , ipilimumab , Tafinlar , Mekinist , More... Aldesleukin Rating 1 User Review 10 /10 1 User Review 10 Rate it! premier
improvement Aldesleukin top-of-the-line
EmoticonEmoticon